Different CHI3L1 concentrations below and above 170 ng/ml (100, 300 and 600 ng/ml), a cut-off value that was demonstrated to have prognostic implications in CIS patients2, were tested for 24 and 48 hours. This evidence concerns the gene CHI3L1 and in situ carcinoma.